EVALUATION OF RENAL CHANGES IN SICKLE CELL DISEASE IN A REFERRAL GOVERNMENT INSTITUTE OF SOUTHERN ODISHA

BIJAYA KUMAR BEHERA; SUSANTA SEKHAR BEHERA; SUKANTA KUMAR JENA; RAKESH MOHANTY; NISARG BEHERA

doi:10.22159/ajpcr.2021.v14i11.42869

Authors

BIJAYA KUMAR BEHERA Department of General Medicine, MKCG Medical College and Hospital, Berhampur, Odisha, India.
SUSANTA SEKHAR BEHERA Department of General Medicine, MKCG Medical College and Hospital, Berhampur, Odisha, India.
SUKANTA KUMAR JENA Department of Radiodiagnosis, MKCG Medical College and Hospital, Berhampur, Odisha, India.
RAKESH MOHANTY Department of General Medicine, MKCG Medical College and Hospital, Berhampur, Odisha, India.
NISARG BEHERA Department of General Medicine, MKCG Medical College and Hospital, Berhampur, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i11.42869

Keywords:

Sickle cell disease, Sickle cell anaemia, Sickle cell trait, Chronic kidney disease

Abstract

Objective: The objective of the study was to study various renal manifestations in sickle cell disease (SCD) and to establish a cause and effect relationship with the evaluation of risk factors.

Methods: This prospective observational cross-sectional study was conducted on 82 SCD patients belonging to the age group of 15–50 years of both the genders over a period of 2 years from January 2019 to December 2020 in MKCG Medical College and Hospital, Berhampur, Odisha, India. Eighty-two patients, 32 (39.02%) having sickle cell anemia (SCA) and 50 (60.98%) having sickle cell trait (SCT), admitted to medicine and nephrology wards of the hospital were included in this study. SCD patients with other hemolytic anemia and with renal congenital/structural abnormality and patients with systemic diseases such as diabetes mellitus, systemic hypertension, and systemic lupus erythematosus were excluded from the study. Various laboratory investigations such as complete blood count, hemoglobin (Hb), serum sodium, serum potassium, serum urea, serum creatinine, fasting blood sugar, erythrocyte sedimentation rate, liver function test, urine routine, and microscopic test were carried out. Diagnosis of SCD patients was based on sickling test and high-performance liquid chromatography testing. Radiologic imaging (Sonography for renal changes) was done at radiodiagnosis department of the hospital.

Results: Glomerular and tubular dysfunction was more in SCA (Hb SS) patients than SCT (Hb AS) patients and the abnormality was more in patients in crisis. Albuminuria in 78.12%, hematuria in 46.87%, cast and crystal in 28.12%, epithelial cell in 31.25%, and hyposthenuria in 56.25% were found in SCA patients. In SCT patients, albuminuria in 38%, hematuria in 16%, cast and crystal in 22%, epithelial cell in 12%, and hyposthenuria in 24% were found. All the above findings were more in percentages in crisis patients of both the groups. In SCA, 37.5% and in SCT, 2% were found to have chronic kidney disease.

Conclusion: Renal involvement in the form of glomerular and tubular dysfunction occur in SCD and more in crisis patients, leading to renal complications, and end-stage renal disease.

Downloads

Download data is not yet available.

References

World Health Organization. Management of Hemoglobin Disorders: Report of Joint WHO-TIF Meeting, Nicosia, Cyprus. Geneva: World Health Organization; 2007.

National Health Mission, Guidelines on Hemoglobinopathies in India. Ministry of Health and Family Welfare. India: Government of India; 2016. p. 19.

Kar BC, Satapathy RK, Kulozik AE, Kulozic M, Sirr S, Serjeant BE. Sickle cell disease in Orissa State, India. Lancet 1986;2:1198-201. DOI: https://doi.org/10.1016/S0140-6736(86)92205-1

Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44. DOI: https://doi.org/10.1056/NEJM199406093302303

Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in haemoglobin SC disease: A four-decade observational study of clinical, hematologic and genetic factors. Am J Hematol 2002;70:206-15. DOI: https://doi.org/10.1002/ajh.10140

Khan KR, Patil MM. Study of renal profile in patients of sickle cell disease. Int J Sci Res 2018;7:189.

Andhale RB, Lodha S, Wankhade V. Renal physiological status of sickle cell anemic patients, district Amravati MS India. J Blood Disordes Transf 2013;5:188.

Dhumne UL, Jawade AA. Sickle cell anemia and morbidity in rural population of Chandrapur district Maharashtra, India. Anthropologists 2011;13:61-3. DOI: https://doi.org/10.1080/09720073.2011.11891178

Howard J, Thein SL. Optimal disease management and health monitoring in adults with sickle cell disease. Hematol Am Soc Hematol Educ Prog 2019;2019:505-12. DOI: https://doi.org/10.1182/hematology.2019000055

Guasch A, Cua M, You W, Mitch WE. Sickle cell anemia causes a distinct pattern of glomerular dysfunction. Kidney Int 1997;51:826-33. DOI: https://doi.org/10.1038/ki.1997.116

Sesso R, Almeida MA, Figueiredo MS, Bordin JO. Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 1998;10:1257-62. DOI: https://doi.org/10.1590/S0100-879X1998001000004

Aokai RY, Saad ST. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med 1995;98:432-5. DOI: https://doi.org/10.1016/S0002-9343(99)80341-6

Alvarez O, Lopez-Mitnik G, Zilleruelo-G. Short term follow up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 2008;50:1236-9. DOI: https://doi.org/10.1002/pbc.21520

Abbate M, Joja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974-84. DOI: https://doi.org/10.1681/ASN.2006040377

Wankhade V, Andhale RB, Lodha S. Diverse clinical manifestations in sickle cell anemia: Study in district Amravati, MS India. J Blood Disorders Transf 2013;4:136. DOI: https://doi.org/10.4172/2155-9864.1000136

Keitel HG, Thompson D, Itano HA. Hyposthenuria in sickle cell anemia; a reversible renal defect. J Clin Invest 1956;35:998-1007. DOI: https://doi.org/10.1172/JCI103360

Menye HD, Wandji G, Kaze FF, Teuwafeu DG, Kane Y, Halle M, et al. Chronic kidney disease in sickle cell disease: Prevalence and associated factors in Cameroon. J Clin Nephrol Ren Care 2019;5:48. DOI: https://doi.org/10.23937/2572-3286.1510048

Gosmanova EO, Zaidi S, Wan JY, Adams Graves PE. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease. J Investig Med 2014;62:804-7. DOI: https://doi.org/10.1097/01.JIM.0000446836.75352.72

Bolarinwa RA, Akinlade KS, Kuti MA, Olawale OO, Akinola NO. Renal disease in adult Nigerians with sickle cell anemia: A report of prevalence, clinical features and risk factors. Saudi J Kidney Dis Transpl 2012;23:171-5.